C. elegans Egg-Laying Behavior

Egg-laying assays quantify how the C. elegans hermaphrodite deposits its eggs, a rhythmic behavior organized into active phases (clusters of rapid events) separated by longer inactive phases. The behavior is a classic output of a small, identified circuit: the two serotonergic HSN motor neurons and the VC neurons drive the vulval muscles. Trent, Tsung and Horvitz (1983) isolated the founding set of egg-laying-defective (egl) mutants and, by their differential responses to serotonin and imipramine, traced defects to the HSNs and the vulval musculature.

Because egg-laying is controlled by serotonergic signaling and a well-mapped neuromuscular circuit, the assay is a sensitive read-out of neuromodulation, neuromuscular function and reproductive physiology. The fraction of eggs retained in the uterus and the developmental stage of laid eggs provide quantitative indices of how strongly the behavior is suppressed, and the active/inactive phase structure reports on the timing machinery that patterns the behavior.

ConductVision scores egg-laying from time-lapse video by detecting deposition events and localizing each egg against the plate, automatically computing rate, inter-event interval, and active/inactive phase durations, and supporting retention read-outs. Spatial lay patterns relative to the bacterial lawn and responses to pharmacological challenge are captured per animal, replacing labor-intensive manual egg counting.

The assay underpins research on serotonergic and neuropeptidergic signaling, on the HSN/VC neuromuscular circuit, and on reproductive toxicology, where shifts in egg-laying rate or retention flag chemical effects. Food availability, temperature and animal age strongly modulate the behavior, so they must be standardized; time-lapse imaging across many animals gives the throughput needed for screens.